Anthony Langone is a Nephrology physician affiliated with Vanderbilt University. OpenAlex indexes 81 publications with 2,275 citations (h-index 22); ClinicalTrials.gov lists 2 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
3601 Tvc
Nashville, TN 372320001
Telephone
615-322-3000Provider last certified this registry record 25 Mar 2022.
Clinical trials
- Cognitive Outcomes in Stable Renal Transplant Patients Switched fromTacrolimus to Envarsus XR™
Sponsor: Vanderbilt University Medical Center
- Mycophenolate Mofetil and Rapamycin as Secondary Intervention vs. Continuation of Calcineurin Inhibitors in Patients at Risk for Chronic Renal Allograft Failure
Sponsor: Vanderbilt University Medical Center
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
13 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Veloxis Pharmaceuticals, Inc.Program year20251 payment
- Novo Nordisk IncProgram year20253 payments
- Biogen, Inc.Program year20254 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
47.9%Angiotensin receptor blocker (ARB)11.4%Telmisartan54%Irbesartan37%Losartan Potassium5%Valsartan4%Part D<11 patientsStatin11.2%Pravastatin Sodium50%Atorvastatin Calcium42%Rosuvastatin Calcium8%Part D≥72 patients+ 11 more classes in this area
Metabolism & gastrointestinal
24.7%Corticosteroid8.6%Prednisone100%Part D≥96 patientsProton pump inhibitor8.3%Omeprazole65%Esomeprazole Magnesium21%Pantoprazole Sodium11%Lansoprazole3%Part D<11 patients+ 7 more classes in this area
Nervous system
10.8%SSRI2.3%Trazodone Hcl44%Sertraline Hcl40%Escitalopram Oxalate17%Part D<11 patientsgamma-Aminobutyric Acid A Receptor Positive Modulator2%Zolpidem Tartrate86%Zolpidem Tartrate Er14%Part D<11 patients+ 9 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 2005–2006 per NIH RePORTER. The latest:
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Emphysematous gastritis due to <i>Sarcina ventriculi</i> infection in an immunocompromised adult
Transplant Infectious Disease
2023 - Outcomes of gynecologic cancer surgery during the COVID-19 pandemic: an international, multicenter, prospective CovidSurg-Gynecologic Oncology Cancer study
American Journal of Obstetrics and Gynecology
2022 - Monoclonal antibody treatment for COVID‐19 in solid organ transplant recipients
Transplant Infectious Disease
2021
Similar KOLs
Other experts from the same institution or the same specialty.
William Schaffner, MD
Vanderbilt University
Keith Obstein, MD, MPH
Vanderbilt University
Andrew Jallouk, MD, PhD
Vanderbilt University
Salim Yusuf
Vanderbilt University
Andrew Levey, MD
Tufts Medical Center
Bertram Kasiske, MD
Hennepin Healthcare
Garabed Eknoyan, MD
Baylor College of Medicine
Lawrence Hunsicker, MD
University of Iowa
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”